In a nutshell This study reviewed the effectiveness and safety of safinamide (Xadago) treatment in patients with Parkinson’s disease (PD). Researchers suggested that safinamide improves the outcomes of patients also taking levodopa. Some background PD is a chronic disease that affects more than 10 million people worldwide. It...
Read MoreSide effects or complications-Dyskinesia Posts on Medivizor
Extended-release levodopa treatment increases the ON time of patients with Parkinson’s disease
In a nutshell This study investigated the duration of ON time in patients with Parkinson’s disease treated with levodopa-carbidopa (LD-CD). Researchers suggested that LD-CL extended-release (ER) capsules (Rytary) increased ON time in these patients. Some background Parkinson’s disease affects brain cells. These cells lose their ability to...
Read MoreEvaluating long-term complication associated with Parkinson’s disease
In a nutshell This study investigated the long-term complication of Parkinson's disease and its treatment. Researchers suggested that dyskinesia is related to the severity of Parkinson's disease rather than early levodopa use. Some background Parkinson's disease (PD) is a chronic disease that affects brain cells that control body...
Read MoreGocovri is associated with improved long-term outcomes in Parkinson’s disease
In a nutshell This study investigated the long-term effectiveness and safety of amantadine extended-release (Gocovri) in patients with Parkinson's disease (PD) and dyskinesia (DYS; unusual movements that a person cannot control). Researchers suggested that this treatment is associated with long-term improved outcomes. Some background PD is a...
Read MoreIs levodopa-carbidopa intestinal gel an effective treatment for patients with Parkinson’s disease?
In a nutshell This study investigated the effectiveness and safety of levodopa-carbidopa intestinal gel (LCIG; Duodopa) in the treatment of patients with Parkinson's disease. Researchers suggested that LCIG alone is a safe and effective option as a treatment for these patients. Some background Parkinson disease affects brain cells. These cells...
Read MoreEvaluating rasagiline as add-on therapy in patients with Parkinson’s disease
In a nutshell This study evaluated the safety and effectiveness of rasagiline (Azilect) in patients with Parkinson’s disease (PD) and wearing-off effects (motor symptoms worsen as levodopa wears off before the next dose is taken). This study concluded that rasagiline improved symptoms and quality of life in these patients. Some background PD is...
Read MoreRepetitive transcranial magnetic stimulation to treat Parkinson´s symptoms
In a nutshell This study investigated the effectiveness of repetitive transcranial magnetic stimulation (rTMS) at controlling the symptoms of Parkinson´s patients. Researchers suggested that rTMS reduced the symptoms of these patients. Some background Parkinson’s is a progressive disease. Medications are the main treatment option,...
Read More